227 related articles for article (PubMed ID: 33359176)
1. Hospital variation in responses to safety warnings about power morcellation in hysterectomy.
Xu X; Desai VB; Wright JD; Lin H; Schwartz PE; Gross CP
Am J Obstet Gynecol; 2021 Jun; 224(6):589.e1-589.e13. PubMed ID: 33359176
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.
Desai VB; Wright JD; Lin H; Gross CP; Sallah YH; Schwartz PE; Xu X
Obstet Gynecol; 2019 Aug; 134(2):227-238. PubMed ID: 31348209
[TBL] [Abstract][Full Text] [Related]
3. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
5. Reduced Complications Following Implementation of Laparoscopic Hysterectomy: A Danish Population-based Cohort Study of Minimally Invasive Benign Gynecologic Surgery between 2004 and 2018.
Settnes A; Topsoee MF; Moeller C; Dueholm M; Kopp TI; Norrbom C; Rasmussen SC; Froeslev PA; Joergensen A; Dreisler E; Gimbel H
J Minim Invasive Gynecol; 2020; 27(6):1344-1353.e3. PubMed ID: 31740432
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.
Matsushita T; Sekizawa A; Jacobs LK
J Minim Invasive Gynecol; 2020 Jan; 27(1):178-185.e1. PubMed ID: 30936031
[TBL] [Abstract][Full Text] [Related]
7. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
8. Minimally Invasive Hysterectomy and Power Morcellation Trends in a West Coast Integrated Health System.
Zaritsky E; Tucker LY; Neugebauer R; Chou T; Flanagan T; Walter AJ; Raine-Bennett T
Obstet Gynecol; 2017 Jun; 129(6):996-1005. PubMed ID: 28486359
[TBL] [Abstract][Full Text] [Related]
9. Trends in Mode of Hysterectomy After the U.S. Food and Drug Administration Power Morcellation Advisory.
Ottarsdottir H; Cohen SL; Cox M; Vitonis A; Einarsson JI
Obstet Gynecol; 2017 Jun; 129(6):1014-1021. PubMed ID: 28486371
[TBL] [Abstract][Full Text] [Related]
10. Complications in Laparoscopic Supracervical Hysterectomy(LASH), especially the morcellation related.
Krentel H; De Wilde RL
Best Pract Res Clin Obstet Gynaecol; 2016 Aug; 35():44-50. PubMed ID: 26694587
[TBL] [Abstract][Full Text] [Related]
11. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
12. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
13. [Hysterectomy for benign gynaecological disease: Surgical approach, vaginal suture method and morcellation: Guidelines].
Gauthier T; Huet S; Marcelli M; Lamblin G; Chêne G;
J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1168-82. PubMed ID: 26527018
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy Practice Patterns in the Postmorcellation Era.
Jorgensen EM; Modest AM; Hur HC; Hacker MR; Awtrey CS
Obstet Gynecol; 2019 Apr; 133(4):643-649. PubMed ID: 30870280
[TBL] [Abstract][Full Text] [Related]
15. Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.
Mehta A; Xu T; Hutfless S; Makary MA; Sinno AK; Tanner EJ; Stone RL; Wang K; Fader AN
Am J Obstet Gynecol; 2017 May; 216(5):497.e1-497.e10. PubMed ID: 28034651
[TBL] [Abstract][Full Text] [Related]
16. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy.
Barron KI; Richard T; Robinson PS; Lamvu G
Obstet Gynecol; 2015 Dec; 126(6):1174-1180. PubMed ID: 26595561
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
18. Impact of power morcellator removal on hysterectomy practice patterns.
Wesol A; Woolley S
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():41-44. PubMed ID: 28599164
[TBL] [Abstract][Full Text] [Related]
19. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
Zullo F; Venturella R; Raffone A; Saccone G
Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic supracervical hysterectomy with transcervical morcellation: initial experience.
Rosenblatt P; Makai G; DiSciullo A
J Minim Invasive Gynecol; 2010; 17(3):331-6. PubMed ID: 20417424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]